Moxifloxacin vs Pembrolizumab
Moxifloxacin vs Pembrolizumab: Overview
This comparison examines the pharmacological differences between Moxifloxacin and Pembrolizumab.
Mechanism of Action
Moxifloxacin: Fourth-generation fluoroquinolone inhibiting DNA gyrase and topoisomerase IV with enhanced anaerobic activity.
Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.
Pharmacokinetics
Half-life: Moxifloxacin — 12 hours; Pembrolizumab — 26 days.
Chemical Properties
Molecular Formula: Moxifloxacin — C21H24FN3O4.
Molecular Weight: Moxifloxacin — 401.4350 g/mol.
Type: Moxifloxacin — Small molecule; Pembrolizumab — Antibody.